[1] Francesmonneris A,Pincus H,First M.Diagnostic and statistical manual of mental disorders:DSM-V[M].Washington DC:American Psychiatric Association, 2013.
[2] Maenner MJ,Shaw KA,Bakian AV,et al.Prevalence and characteristics of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2018[J].MMWR Surveill Summ,2021,70(11):1-16.
[3] Saghazadeh A,Ataeinia B,Keynejad K,et al.A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders:Effects of age, gender, and latitude[J].J Psychiatr Res,2019,115:90-102.
[4] Saghazadeh A,Ataeinia B,Keynejad K,et al.Anti-inflammatory cytokines in autism spectrum disorders:A systematic review and meta-analysis[J].Cytokine,2019,123:154740.
[5] Siniscalco D,Sapone A,Giordano C,et al.The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients[J].J Autism Dev Disord,2012,42(7):1403-1410.
[6] Bennabi M,Tarantino N,Gaman A,et al.Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders:stigma/consequence of unresolved early infectious events?[J].Mol Autism,2019,10:22.
[7] Enstrom AE,Lit L,Onore CE,et al.Altered gene expression and function of peripheral blood natural killer cells in children with autism[J].Brain Behav Immun,2009,23(1):124-133.
[8] Rose DR,Careaga M,van de Water J,et al.Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation[J].Brain Behav Immun,2017,63:60-70.
[9] Custódio CS,Mello BSF,Filho A,et al.Neonatal immune challenge with lipopolysaccharide triggers long-lasting sex-and age-related behavioral and immune/neurotrophic alterations in mice:relevance to autism spectrum disorders[J].Mol Neurobiol,2018,55(5):3775-3788.
[10] Vargas DL,Nasclmbene C,Krishnan C,et al.Neuroglial activation and neuroinflammation in the brain of patients with autism[J].Ann Neurol,2005,57(1):67-81.
[11] Careaga M,Ashwood P.Autism spectrum disorders:from immunity to behavior[J].Methods Mol Biol,2012,934:219-240.
[12] Tsilioni I,Patel AB,Pantazopoulos H,et al.IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin[J].Proc Natl Acad Sci U S A,2019,116(43):21659-21665.
[13] Yang I, Hang SJ, Kaar G,et al.The role of microglia in central nervous system immunity and glioma immunology[J].J Clin Neurosci,2010,17(1):6-10.
[14] Janda E,Boi L,Carta AR.Microglial phagocytosis and its regulation:a therapeutic target in parkinson's disease?[J].Front Mol Neurosci,2018,11:144.
[15] Tsilioni I,Theoharides TC.Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β[J].J Neuroinflammation,2018,15(1):239.
[16] Morgan JT,Chana G,Pardo CA,et al.Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism[J].Biol Psychiatry,2010,68(4):368-376.
[17] Suzuki K,Sugihara G,Ouchi Y,et al.Microglial activation in young adults with autism spectrum disorder[J].JAMA Psychiatry,2013,70(1):49-58.
[18] Eldin J,Tracy LB,Christopher LH,et al.Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain[J].Endocrinology,2015,156(9):3265-3276.
[19] Hind WH, Tufarelli G, Neophytou M, et al.Endocannabinoids modulate human blood-brain barrier permeability in vitro[J].Brit J Pharmacol,2015,172(12):3015-3027.
[20] Pál P,Sándor B,George K.The endocannabinoid system as an emerging target of pharmacotherapy[J].Pharmacol Rev,2006,58(3):389-462.
[21] Kwan CKA,Hassendrini P,Geoffrey W,et al.The Interplay between the endocannabinoid system, epilepsy and cannabinoids[J].Int J Mol Sci,2019,20(23):6079.
[22] Xu JY,Chen C. Endocannabinoids in synaptic plasticity and neuroprotection[J].Neuroscientist,2015,21(2):152-168.
[23] Wolf SA, Ullrich D.Endocannabinoids and the brain immune system:new neurones at the horizon?[J].J Neuroendocrinol,2008,20 (Suppl 1):15-19.
[24] Mecha M,Yanguas-Casás N,Feliú A,et al.The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia[J].Brain Behav Immun,2019,77:110-126.
[25] Frida L,Stefania P,Leyre M,et al.Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide[J].Eur J Neurosci,2008,28(4):633-641.
[26] Fernández-Suárez D,Celorrio M,Riezuh Boj JI, et al.Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model[J].Neurobiol Aging,2014,35(11):2603-2616.
[27] Kelly R,Joers V,Tansey MG,et al.Microglial phenotypes and their relationship to the cannabinoid system:therapeutic implications for parkinson's disease[J].Molecules,2020,25(3):453.
[28] Talarico G,Trebbastoni A,Bruno G,et al.Modulation of the cannabinoid system:a new perspective for the treatment of the alzheimer's disease[J].Curr Neuropharmacol,2019,17(2):176-183.
[29] Navarro G,Borroto-Escuela D,Angelats E,et al.Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia.Role of CB(1) and CB(2) receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia[J].Brain Behav Immun,2018,67:139-151.
[30] Kempuraj D,Thangavel R,Natteru PA,et al.Neuroinflammation induces neurodegeneration[J].J Neurol Neurosurg Spine,2016,1(1):1003.
[31] 李德欣.ASD 儿童 eCB 系统表达水平及其与表型特征的关联研究[D].哈尔滨:哈尔滨医科大学,2020.
[32] Servadio M,Melancia F,Manduca A,et al.Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid[J].Transl Psychiatry,2016,6(9):e902.
[33] Kerr DM,Downey L,Conboy M,et al.Alterations in the endocannabinoid system in the rat valproic acid model of autism[J].Behav Brain Res,2013,249:124-132.
[34] Aran A,Eylon M,Harel M,et al.Lower circulating endocannabinoid levels in children with autism spectrum disorder[J].Mol Autism,2019,10:2.
[35] Habib SS,Al-Regaiey K,Bashir S,et al.Role of Endocannabinoids on neuroinflammation in autism spectrum disorder prevention[J].J Clin Diagn Res,2017,11(6):ce01-ce03.
[36] Antonucci N,Cirillo A,Siniscalco D.Beneficial effects of palmitoylethanolamide on expressive language, cognition, and behaviors in autism:a report of two cases[J].Case Rep Psychiatry,2015,2015:325061.
[37] Bertolino B,Crupi R,Impellizzeri D,et al.Beneficial effects of co-ultramicronized palmitoylethanolamide/luteolin in a mouse model of autism and in a case report of autism[J].CNS Neurosci Ther,2017,23(1):87-98.
[38] Wei D,Dinh D,Lee D,et al.Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment[J].Cannabis Cannabinoid Res,2016,1(1):81-89.
[39] Erica Z,Marina G,Marie W-R,et al.Cannabidivarin treatment ameliorates autism-like behaviors and restores hippocampal endocannabinoid system and glia alterations induced by prenatal valproic acid exposure in rats[J].Front Cell Neurosci,2019,13:367.